Literature DB >> 9833987

Effect of ultrasound application on skin metabolism of prednisolone 21-acetate.

T Hikima1, Y Hirai, K Tojo.   

Abstract

PURPOSE: The effect of ultrasound on skin penetration and metabolism of prednisolone (PN) and prednisolone 21-acetate (PNA) was investigated in the hairless mouse skin in vitro.
METHODS: The abdominal skin excised freshly was pretreated under different ultrasound intensities (4.32, 2.88, and 1.50 W/cm2) for 10, 30, and 60 min. The penetration/metabolism rate of PNA and its metabolite (PN) was then measured using a side-by-side diffusion cell.
RESULTS: The skin penetration of PN was enhanced by the ultrasound pretreatment. This enhancement was attributed to the decrease in the stratum corneum barrier capacity by ultrasound energy. The steady-state appearance rate of PN following the skin bioconversion of PNA decreased appreciably with increasing the product of the duration of pretreatment (Dp, min) and the intensity of ultrasound applied (Iu, W/cm2). When the product value was less than 40 W/cm2 . min, the steady-state appearance rate of the PN hardly increased in spite of the penetration enhancement of PNA.
CONCLUSIONS: These findings indicated a possible deactivation of the skin enzymes by ultrasound energy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833987     DOI: 10.1023/a:1011944209274

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery.

Authors:  D Bommannan; G K Menon; H Okuyama; P M Elias; R H Guy
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

2.  Transdermal drug delivery using low-frequency sonophoresis.

Authors:  S Mitragotri; D Blankschtein; R Langer
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

3.  Ultrasonically mediated solute permeation through polymer barriers.

Authors:  T N Julian; G M Zentner
Journal:  J Pharm Pharmacol       Date:  1986-12       Impact factor: 3.765

4.  Ultrasound-mediated transdermal protein delivery.

Authors:  S Mitragotri; D Blankschtein; R Langer
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

Review 5.  Ultrasonically mediated drug delivery.

Authors:  J Saxena; N Sharma; M C Makoid; U V Banakar
Journal:  J Biomater Appl       Date:  1993-01       Impact factor: 2.646

6.  Effect of free radical scavengers on changes in ion conductance during exposure to therapeutic ultrasound.

Authors:  M A Adinno; A M al-Karmi; D A Stoltz; J C Matthews; L A Crum
Journal:  Membr Biochem       Date:  1993 Oct-Dec

7.  The effect of ultrasound on the percutaneous absorption of lignocaine.

Authors:  J C McElnay; M P Matthews; R Harland; D F McCafferty
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

Review 8.  Free radical formation induced by ultrasound and its biological implications.

Authors:  P Riesz; T Kondo
Journal:  Free Radic Biol Med       Date:  1992-09       Impact factor: 7.376

9.  Ultrasonic treatment of experimental animal tumours.

Authors:  F W Kremkau
Journal:  Br J Cancer Suppl       Date:  1982-03

10.  Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine.

Authors:  K Tachibana; S Tachibana
Journal:  Anesthesiology       Date:  1993-06       Impact factor: 7.892

  10 in total
  3 in total

Review 1.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

Review 2.  Physically facilitating drug-delivery systems.

Authors:  Jorge I Rodriguez-Devora; Sunny Ambure; Zhi-Dong Shi; Yuyu Yuan; Wei Sun; Tao Xui
Journal:  Ther Deliv       Date:  2012-01

3.  Electrically and Ultrasonically Enhanced Transdermal Delivery of Methotrexate.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Pharmaceutics       Date:  2018-08-05       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.